PresentationNicholas AshworthHead of Investor Relations Good morning, everybody, and welcome to Reckitt's Q3 trading update. I'm here with our CEO, Kris Licht, and our CFO, Shannon Eisenhardt, who will take you through some prepared remarks and then we will take your questions. Before we start, I would like to draw your attention to the usual disclaimer in respect to forward-looking statements contained on Page 7 of our results statement published this morning. And with that said, I'll hand over to Kris to ...

Reckitt Benckiser sales rose more than expected as the London-based consumer goods company reports strong growth in some regions https://t.co/uWWXvFK9l2 ...

Company Overview - Reckitt Benckiser Group PLC (RBGLY) currently holds a Momentum Style Score of B, indicating a positive momentum outlook [3] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [4] Price Performance - Over the past week, RBGLY shares have increased by 1.56%, matching the performance of the Zacks Soap and Cleaning Materials industry [6] - In a longer time frame, RBGLY shares have risen by 13.26% over the past quarter and 28.22% over the last year, outperforming the S&P 500, which increased by 11.05% and 18.96% respectively [7] Trading Volume - The average 20-day trading volume for RBGLY is 342,330 shares, which serves as a useful baseline for assessing price movements [8] Earnings Outlook - In the past two months, one earnings estimate for RBGLY has been revised upwards, while none have been lowered, leading to an increase in the consensus estimate from $0.93 to $0.94 [10] - For the next fiscal year, one estimate has also moved upwards with no downward revisions during the same period [10] Conclusion - Given the positive price trends, trading volume, and earnings outlook, RBGLY is positioned as a promising investment opportunity with a Momentum Score of B [12]

Group 1 - The event features a presentation by Reckitt, with representatives Kris and Shannon attending to support the conference [1] - The format of the event includes a fireside chat followed by a breakout session for attendees [2]

Core Viewpoint - Reckitt Benckiser Group PLC (RBGLY) has received an upgrade to Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with stock price movements, particularly due to institutional investors adjusting their valuations based on these estimates [4][6]. - For the fiscal year ending December 2025, Reckitt Benckiser Group is expected to earn $0.94 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 2.5% over the past three months [8]. Investment Implications - The upgrade to Zacks Rank 2 positions Reckitt Benckiser Group in the top 20% of Zacks-covered stocks, suggesting potential for market-beating returns in the near term due to improved earnings outlook [10]. - The Zacks Rank system maintains a balanced approach, with only the top 20% of stocks receiving favorable ratings, indicating a strong earnings estimate revision feature for Reckitt Benckiser Group [9][10].

Group 1 - Carlsberg AS (CABGY) has gained approximately 23.7% year-to-date, significantly outperforming the average gain of 4.5% in the Consumer Staples sector [4] - The Zacks Rank for Carlsberg AS is currently 2 (Buy), indicating a positive earnings outlook with a 1.7% increase in the consensus estimate for full-year earnings over the past quarter [3] - Carlsberg AS belongs to the Beverages - Alcohol industry, which is ranked 178 in the Zacks Industry Rank, and has outperformed this group, which has seen a loss of about 1.5% year-to-date [5] Group 2 - Reckitt Benckiser Group PLC (RBGLY) has also shown strong performance with a year-to-date return of 24%, and it holds a Zacks Rank of 2 (Buy) [4][5] - The Soap and Cleaning Materials industry, to which Reckitt Benckiser belongs, is currently ranked 2, indicating strong performance relative to other industries [6] - Both Carlsberg AS and Reckitt Benckiser Group PLC are highlighted as stocks to watch for investors interested in the Consumer Staples sector due to their solid performance [6]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Reckitt Benckiser Group plc regarding a class action lawsuit related to misleading statements made by the company during a specified class period [1][3]. Group 1: Class Action Details - The class period for the lawsuit is from January 13, 2021, to July 28, 2024 [3]. - Allegations include that Reckitt's cow's milk-based formula, Enfamil, posed an increased risk of NEC in preterm infants, which was not disclosed, impacting sales and exposing the company to legal claims [3]. - The lawsuit claims that positive statements made by Reckitt regarding its business and operations were materially false and misleading [3]. Group 2: Shareholder Actions - Shareholders are encouraged to register for the class action by the deadline of August 4, 2025, to potentially become lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [4]. - Participation in the case incurs no cost or obligation for shareholders [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [5].

Core Viewpoint - The Rosen Law Firm is reminding purchasers of Reckitt Benckiser Group PLC's American Depositary Shares (ADSs) of a class action lawsuit with a lead plaintiff deadline of August 4, 2025, for those who bought shares between January 13, 2021, and July 28, 2024 [1][2]. Group 1: Class Action Details - Investors who purchased Reckitt ADSs during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the deadline [2]. - The lawsuit alleges that Reckitt failed to warn investors about the increased risk of necrotizing enterocolitis (NEC) in preterm infants due to its cow's milk-based formula, Enfamil, which misled investors regarding the company's business prospects [4]. Group 2: Rosen Law Firm's Credentials - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company at the time [3]. - The firm has been consistently ranked among the top firms for securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3].

Core Viewpoint - A class action lawsuit has been filed against Reckitt Benckiser Group plc for allegedly misleading investors regarding the risks associated with its cow's milk-based formula, Enfamil, which is linked to a serious health risk in premature infants [1][4]. Group 1: Lawsuit Details - The class action lawsuit is filed in the United States District Court for the Southern District of New York on behalf of investors who purchased Reckitt securities between January 13, 2021, and July 28, 2024 [1]. - Investors have until August 4, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit [1]. - The lawsuit claims that Reckitt failed to adequately warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants consuming its formula [3][4]. Group 2: Allegations Against Reckitt - The lawsuit alleges that Reckitt made misleading statements and omissions regarding its business, financial condition, and prospects during the class period [4]. - Specific allegations include failing to disclose the risks associated with Enfamil, the potential impact on sales, and the exposure to legal claims [4]. - As a result of these omissions, Reckitt's positive statements about its business were deemed materially false and misleading [4]. Group 3: Company Background - Reckitt is a UK-based global consumer goods company facing over 500 product liability lawsuits related to its infant formula [3]. - The lawsuits claim that Reckitt and its competitor Abbott Laboratories did not adequately warn about the risks associated with their cow milk-based formulas [3]. Group 4: Legal Representation - Bragar Eagel & Squire, P.C. is representing the investors in this class action lawsuit and encourages affected individuals to reach out for more information [1][5]. - The firm specializes in representing individual and institutional investors in complex litigation [6].

Company Overview - Reckitt Benckiser Group PLC (RBGLY) currently holds a Momentum Style Score of B, indicating potential for strong performance based on recent trends [3][12] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned favorably in the market [4][12] Price Performance - Over the past week, RBGLY shares have increased by 11.73%, matching the performance of the Zacks Soap and Cleaning Materials industry [6] - In the last month, RBGLY's price change is 8.09%, again in line with the industry's performance [6] - For longer-term metrics, RBGLY shares have risen 15.8% over the past three months and 41.39% over the last year, outperforming the S&P 500, which increased by 14.12% and 16.19% respectively [7] Trading Volume - The average 20-day trading volume for RBGLY is 285,846 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, three earnings estimates for RBGLY have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $0.92 to $0.94 [10] - For the next fiscal year, three estimates have also moved upwards without any downward revisions [10]